D20054;LITT for Spine Tumors
ConditionSpinal Metastases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDartmouth-Hitchcock Medical Center
About this trial
The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.
Eligibility criteria
Qualifiers
Histology confirmed spinal tumor involving the T2-T12 spine segments.
Indication for spine stereotactic radiosurgery or palliative intervention.
Normal neurologic exam at the time of presentation (Frankel grade E).
Disqualifiers
Contraindication to MRI
ANY neurologic deficit
Tumor spanning more than 3 consecutive vertebral segments
Contraindication to general anesthesia
Trial design
Treatments tested in this trial
- ClearPoint Prism
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov